Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Cancer Journal (Sudbury, Mass.)
|
March 28, 2015
Novel therapeutic targets of tumor metabolism
Rigel J Kishton, Jeffrey C Rathmell
Cell Research
|
August 24, 2022
Fine-tuning T cell function through engineered orthogonal chimeric cytokine receptors
Rigel J Kishton, Nicholas P Restifo
Nature Cancer
|
December 17, 2024
T cells lead the charge against solid tumors
Rigel J Kishton, Nicholas P Restifo
Cell Metabolism
|
July 7, 2017
Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy
Rigel J Kishton, Madhusudhanan Sukumar, Nicholas P Restifo
Current Opinion in Immunology
|
April 17, 2017
Metabolic reprograming of anti-tumor immunity
Madhusudhanan Sukumar, Rigel J Kishton, Nicholas P Restifo
Cell Metabolism
|
November 10, 2016
Arginine Arms T Cells to Thrive and Survive
Rigel J Kishton, Madhusudhanan Sukumar, Nicholas P Restifo
Cell
|
October 30, 2020
Strength in Numbers: Identifying Neoantigen Targets for Cancer Immunotherapy
Rigel J Kishton, Rachel C Lynn, Nicholas P Restifo
Nature Medicine
|
October 9, 2019
Developing neoantigen-targeted T cell-based treatments for solid tumors
Tori N Yamamoto, Rigel J Kishton, Nicholas P Restifo
Nature Reviews. Immunology
|
July 12, 2016
A guide to immunometabolism for immunologists
Luke A J O'Neill, Rigel J Kishton, Jeff Rathmell
Current Opinion in Immunology
|
October 28, 2021
Next generation immunotherapy: enhancing stemness of polyclonal T cells to improve anti-tumor activity
Rigel J Kishton, Suman K Vodnala, Raul Vizcardo, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Cancer Journal (Sudbury, Mass.)
|
March 28, 2015
Novel therapeutic targets of tumor metabolism
Rigel J Kishton, Jeffrey C Rathmell
Cell Research
|
August 24, 2022
Fine-tuning T cell function through engineered orthogonal chimeric cytokine receptors
Rigel J Kishton, Nicholas P Restifo
Nature Cancer
|
December 17, 2024
T cells lead the charge against solid tumors
Rigel J Kishton, Nicholas P Restifo
Cell Metabolism
|
July 7, 2017
Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy
Rigel J Kishton, Madhusudhanan Sukumar, Nicholas P Restifo
Current Opinion in Immunology
|
April 17, 2017
Metabolic reprograming of anti-tumor immunity
Madhusudhanan Sukumar, Rigel J Kishton, Nicholas P Restifo
Cell Metabolism
|
November 10, 2016
Arginine Arms T Cells to Thrive and Survive
Rigel J Kishton, Madhusudhanan Sukumar, Nicholas P Restifo
Cell
|
October 30, 2020
Strength in Numbers: Identifying Neoantigen Targets for Cancer Immunotherapy
Rigel J Kishton, Rachel C Lynn, Nicholas P Restifo
Nature Medicine
|
October 9, 2019
Developing neoantigen-targeted T cell-based treatments for solid tumors
Tori N Yamamoto, Rigel J Kishton, Nicholas P Restifo
Nature Reviews. Immunology
|
July 12, 2016
A guide to immunometabolism for immunologists
Luke A J O'Neill, Rigel J Kishton, Jeff Rathmell
Current Opinion in Immunology
|
October 28, 2021
Next generation immunotherapy: enhancing stemness of polyclonal T cells to improve anti-tumor activity
Rigel J Kishton, Suman K Vodnala, Raul Vizcardo, et al.
Page
of 4